If you have any questions regarding your submission please contact the Annual Meeting team.Notifications: Notifications will be sent to the submitting author by Friday, April 27, 2018.Late-breaking Abstract Submission Site Opens: July 18, 2018Late-breaking Abstract Submission Site Closes: August 1, 2018 at 11:59 p.m. Pacific time
New for 2018, all poster viewing presentations will be displayed as electronic posters! Posters will be integrated into the Exhibit Hall in a new and exciting floorplan that will offer large, touchscreen monitors and an interactive format for all poster presenters. No more paper posters, tubes or poster printing!The electronic format will allow for:
ASTRO’S Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year. During the 2018 Annual Meeting we will showcase the unique ability of radiation to cure cancer. We will emphasize new scientific discoveries and how to translate these new findings into clinical applications, and opportunities for cure. The meeting program will continue to spotlight the importance of palliation and supportive care.
The scientific program is the ideal platform to bring together clinicians, scientists and researchers from all oncology disciplines to exchange ideas, promote multidisciplinary care and address the educational and professional development interests of our attendees. Scientific and educational sessions will cover specific clinical areas including breast, central nervous system, gastrointestinal, genitourinary, gynecologic, head and neck, immunotherapy, lymphoma, musculoskeletal, pediatric, sarcoma and thoracic cancers.
Radiation biology and radiation physics concepts will be explored in their own tracks. The Annual Meeting will feature a continued emphasis on patient quality and safety issues in the delivery of radiation therapy in the areas of treatment techniques, equipment, terminology and professional responsibilities. Program content has been designed to address specific, documented and clinically important practice gaps in physician knowledge, competence and performance.
Abstracts will be scored by blind peer review based on the following criteria:
Specific questions for prospective Clinical Trials:
Specific questions for retrospective observational studies:
ASTRO is an accredited provider of continuing medical education and adheres to the policies and standards set forth by the Accreditation Council for Continuing Medical Education (ACCME). As such, abstract authors are required to disclose relationships with commercial interests. A commercial interest is defined as "any entity developing, producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients."
To ensure its compliance, ASTRO expects that the content and related materials will promote improvements or quality in health care and not a specific proprietary business interest or commercial bias.
We employ several strategies to ensure absence of bias:
All abstracts submitted to the ASTRO Annual Meeting are embargoed until the date and time of presentation unless otherwise noted by ASTRO. The submitting author is responsible for conveying this information to all co-authors. All abstracts accepted for presentation at the ASTRO Annual Meeting may be highlighted in ASTRO’s Press Program. All submitters agree to cooperate in the publicity of their study. For questions regarding the embargo or press policy, please contact ASTRO’s Media Relations Team.